These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23686485)

  • 1. Host B7-H4 regulates antitumor T cell responses through inhibition of myeloid-derived suppressor cells in a 4T1 tumor transplantation model.
    Leung J; Suh WK
    J Immunol; 2013 Jun; 190(12):6651-61. PubMed ID: 23686485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
    Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
    Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.
    Leung J; St-Onge P; Stagg J; Suh WK
    Cancer Immunol Immunother; 2017 Apr; 66(4):491-502. PubMed ID: 28074226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous expression of B7-H4 improves long-term murine islet allograft survival.
    Wang X; Hao J; Metzger DL; Mui A; Lee IF; Akhoundsadegh N; Ao Z; Chen L; Ou D; Verchere CB; Warnock GL
    Transplantation; 2013 Jan; 95(1):94-9. PubMed ID: 23192157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells.
    Qian Y; Hong B; Shen L; Wu Z; Yao H; Zhang L
    Cell Tissue Res; 2013 Jul; 353(1):139-51. PubMed ID: 23660627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape.
    Chen C; Qu QX; Shen Y; Mu CY; Zhu YB; Zhang XG; Huang JA
    Cancer Lett; 2012 Apr; 317(1):99-105. PubMed ID: 22108530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.
    Rahbar R; Lin A; Ghazarian M; Yau HL; Paramathas S; Lang PA; Schildknecht A; Elford AR; Garcia-Batres C; Martin B; Berman HK; Leong WL; McCready DR; Reedijk M; Done SJ; Miller N; Youngson B; Suh WK; Mak TW; Ohashi PS
    Cancer Immunol Res; 2015 Feb; 3(2):184-95. PubMed ID: 25527357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.
    Dangaj D; Lanitis E; Zhao A; Joshi S; Cheng Y; Sandaltzopoulos R; Ra HJ; Danet-Desnoyers G; Powell DJ; Scholler N
    Cancer Res; 2013 Aug; 73(15):4820-9. PubMed ID: 23722540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity.
    Xue Q; Luan XY; Gu YZ; Wu HY; Zhang GB; Yu GH; Zhu HT; Wang M; Dong W; Geng YJ; Zhang XG
    Stem Cells Dev; 2010 Jan; 19(1):27-38. PubMed ID: 19788399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality.
    Saha A; Taylor PA; Lees CJ; Panoskaltsis-Mortari A; Osborn MJ; Feser CJ; Thangavelu G; Melchinger W; Refaeli Y; Hill GR; Munn DH; Murphy WJ; Serody JS; Maillard I; Kreymborg K; van den Brink M; Dong C; Huang S; Zang X; Allison JP; Zeiser R; Blazar BR
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H4-Ig treatment of normal mice changes lymphocyte homeostasis and increases the potential of regulatory T cells.
    Kristensen NN; Schmidt EG; Rasmussen S; Balk-Møller E; Claesson MH
    Immunopharmacol Immunotoxicol; 2013 Aug; 35(4):505-13. PubMed ID: 23841452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-H4 induces donor-specific tolerance in mouse islet allografts.
    Wang X; Hao J; Metzger DL; Mui A; Ao Z; Verchere CB; Chen L; Ou D; Warnock GL
    Cell Transplant; 2012; 21(1):99-111. PubMed ID: 21929869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
    Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M
    J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.
    Iizuka A; Nonomura C; Ashizawa T; Kondou R; Ohshima K; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Akiyama Y
    Clin Cancer Res; 2019 May; 25(9):2925-2934. PubMed ID: 30737243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of B7-H4 in tumor infiltrated dendritic cells.
    Cheng C; Qu QX; Shen Y; Lv YT; Zhu YB; Zhang XG; Huang JA
    J Immunoassay Immunochem; 2011; 32(4):353-64. PubMed ID: 21728826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8
    Li J; Lee Y; Li Y; Jiang Y; Lu H; Zang W; Zhao X; Liu L; Chen Y; Tan H; Yang Z; Zhang MQ; Mak TW; Ni L; Dong C
    Immunity; 2018 Apr; 48(4):773-786.e5. PubMed ID: 29625896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional hierarchy and relative contribution of the CD28/B7 and ICOS/B7-H2 costimulatory pathways to T cell-mediated delayed-type hypersensitivity.
    Wong SC; Tan AH; Lam KP
    Cell Immunol; 2009; 256(1-2):64-71. PubMed ID: 19249753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells.
    Miao G; Sun X
    Biomed Pharmacother; 2021 Sep; 141():111913. PubMed ID: 34328096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target.
    MacGregor HL; Ohashi PS
    Clin Cancer Res; 2017 Jun; 23(12):2934-2941. PubMed ID: 28325750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.